The U.S. Food and Drug Administration issued a voluntary recall on Friday of a drug commonly used to control blood pressure and prevent heart failure.
Scroll down to continue reading
More news from KIRO 7
- 13-year-old girl beheaded after seeing grandmother killed in Alabama cemetery
- Seattle crews responding for water rescue near Discovery Park
- Police: Man tried to kidnap two women in two Renton stores
- Seattle police accept lip sync battle challenge
- Child molester beaten to death 5 days after prison arrival, authorities say
The recall is due to the presence of an impurity, N-nitrosodimethylamine (NDMA). It is an organic chemical that is often used in rocket fuel, softeners and lubricants.
NDMA is a known cancer risk. Studies on animals show that NDMA can be toxic and cause tumors to the liver, kidney and respiratory tract. Humans exposed to high levels of NDMA can experience liver damage that could result in cancer, according to the US Department of Health and Human Services.
Drug manufacturers affected include Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries, Ltd.
The recall also includes valsartan/hydrochlorothiazide (HCTZ) medication sold by Solco Healthcare and Teva Pharmaceuticals Industries, Ltd.
“We have carefully assessed the valsartan-containing medications sold in the United States, and we've found that the valsartan sold by these specific companies does not meet our safety standards,” said Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research. “This is why we've asked these companies to take immediate action to protect patients.”
The FDA’s investigation into the drugs are ongoing.
Experts warn that patients who are on heart-monitoring medication should talk to their doctor to see if their prescriptions are affected.
© 2020 Cox Media Group